Azelnidipine and Telmisartan Tablets

AZELIKEM T 40, manufactured by Steris Healthcare, is a dual-action antihypertensive combination formulated with Azelnidipine 16 mg and Telmisartan 40 mg. This fixed-dose combination brings together a long-acting dihydropyridine calcium channel blocker (Azelnidipine) and an angiotensin receptor blocker (Telmisartan) in a single tablet, designed for the long-term management of hypertension (high blood pressure) in adults who require combination therapy to achieve consistent, well-tolerated blood pressure control.

Why It's Important

Hypertension is frequently called a "silent" condition because it often produces no obvious symptoms while quietly damaging blood vessels, the heart, kidneys, and brain over years of exposure. Left uncontrolled, persistently high blood pressure significantly increases the risk of heart attack, stroke, chronic kidney disease, and other serious cardiovascular complications. A substantial number of hypertensive patients cannot achieve adequate control with a single antihypertensive agent alone, which is why major hypertension management guidelines increasingly favor combination therapy as a first-line approach for patients with moderate to severe blood pressure elevation.

This is precisely where azelnidipine and telmisartan tablets demonstrate real clinical value. Telmisartan works by blocking the angiotensin II receptor, preventing a hormone that constricts blood vessels and drives blood pressure upward from exerting its effect, while also offering meaningful renal-protective benefits — particularly relevant for patients with diabetes or early signs of kidney involvement. Azelnidipine, meanwhile, is a long-acting, highly lipophilic calcium channel blocker known for its smooth, gradual onset of action and extended duration, which translates into stable 24-hour blood pressure control with a notably lower incidence of reflex tachycardia (a common drawback with faster-acting calcium channel blockers) and better overall cardiovascular tolerability. Together, this combination doesn't just reduce blood pressure numbers on paper — it does so through two complementary mechanisms that improve consistency of control, reduce common side effects, and offer added organ-protective benefits, making AZELIKEM T 40 a clinically meaningful choice for patients whose hypertension is not adequately managed on monotherapy.

Key Benefits

What Are the Benefits of This Combination?

• Provides more effective and sustained blood pressure reduction than either Azelnidipine or Telmisartan used alone
• Azelnidipine's gradual onset and long duration of action support smooth, stable blood pressure control without sharp fluctuations
• Lower incidence of reflex tachycardia (rapid heartbeat) compared to some other dihydropyridine calcium channel blockers
• Telmisartan offers additional renal-protective benefits, particularly useful in patients with diabetic nephropathy or early kidney involvement
• Once-daily dosing supports better long-term treatment adherence and simplifies the medication routine
• Consistent 24-hour blood pressure coverage, helping protect against the early-morning blood pressure surge associated with higher cardiovascular event risk
• Suitable for patients with coexisting metabolic conditions, given Telmisartan's largely metabolically neutral profile
• Reduces overall pill burden by combining two complementary antihypertensive mechanisms into a single once-daily tablet

Side Effects

Like all antihypertensive medications, AZELIKEM T 40 may cause side effects in some patients, particularly during the initial weeks of treatment as the body adjusts. Commonly reported effects include mild dizziness, headache, fatigue, flushing, mild ankle or pedal swelling, and occasional gastrointestinal discomfort such as nausea or mild stomach upset. These effects are generally mild to moderate in intensity and tend to improve as treatment continues.

Available Substitutes

Several fixed-dose combinations of Azelnidipine and Telmisartan are available in the Indian pharmaceutical market, differing in individual component strengths (commonly Azelnidipine 8 mg or 16 mg with Telmisartan 20 mg, 40 mg, or 80 mg) and brand. Patients should not switch between different Azelnidipine and Telmisartan brands or strength combinations without consulting their physician, as even modest differences in Telmisartan strength can meaningfully affect blood pressure control and overall tolerability. For a Steris Healthcare-manufactured alternative or a different strength, patients and PCD franchise partners are encouraged to consult the company's product portfolio directly.

Dosage Guidelines

Dosage must always be individualized by a physician based on the patient's baseline blood pressure, response to prior therapy, and any coexisting medical conditions. AZELIKEM T 40 is typically taken once daily, at the same time each day, with or without food, to help maintain steady drug levels and support consistent treatment adherence. Tablets should be swallowed whole with a glass of water and should not be crushed or chewed unless otherwise directed by a physician. Patients should not stop this medication abruptly or skip doses, as effective blood pressure control depends on consistent daily use; any dosage changes should be made only under medical supervision, typically alongside periodic blood pressure monitoring to assess treatment response.

Precautions & Warnings

AZELIKEM T 40 should not be used in patients with a known hypersensitivity to Azelnidipine, Telmisartan, or any of its components, and is contraindicated during pregnancy due to the risk of fetal harm associated with angiotensin receptor blockers, particularly in the second and third trimesters. It should be used with caution in patients with severe hepatic or biliary obstruction, given Telmisartan's route of elimination, and in patients with significant renal artery stenosis. Caution is also advised in patients with heart failure, those on potassium-sparing diuretics or potassium supplements (due to the risk of elevated potassium levels), and elderly patients, who may be more sensitive to the blood pressure–lowering effects of this combination. Patients should inform their physician of all other medications being taken, including NSAIDs, lithium, and other antihypertensive agents, to avoid potential interactions. Regular monitoring of blood pressure, kidney function, and electrolyte levels is generally recommended during long-term therapy.

How to Use & Mechanism of Action

AZELIKEM T 40 should be taken orally, once daily at a consistent time, swallowed whole with a glass of water, with or without food. Its effectiveness comes from the complementary mechanisms of its two components. Telmisartan, an angiotensin II receptor blocker (ARB), works by selectively blocking the AT1 receptor, preventing angiotensin II — a hormone responsible for constricting blood vessels and raising blood pressure — from exerting its effects. This leads to vasodilation, reduced blood pressure, and additional benefits for kidney protection, particularly relevant in patients with diabetes or early-stage nephropathy. Azelnidipine, a long-acting dihydropyridine calcium channel blocker, works by blocking calcium entry into vascular smooth muscle cells, leading to arterial relaxation and reduced peripheral resistance. What distinguishes Azelnidipine from many other calcium channel blockers is its high lipophilicity and gradual receptor-binding kinetics, which produce a smooth, sustained onset of action without the sharp vasodilatory swings that can trigger reflex sympathetic activation and rapid heart rate. Together, Telmisartan's hormonal blockade and Azelnidipine's gradual, sustained vascular relaxation provide smoother, more comprehensive, and better-tolerated blood pressure control than either agent used alone.

Frequently Asked Questions

1. What is AZELIKEM T 40 used for?
AZELIKEM T 40 is used for the long-term management of high blood pressure (hypertension) in adults who need combination therapy to achieve consistent control.

2. What are azelnidipine and telmisartan tablets used for?
This combination is used to lower and control blood pressure by relaxing blood vessels through calcium channel blockade while also blocking the hormone angiotensin II, which otherwise causes vessels to constrict.

3. What is telmisartan 40 mg used for?
Telmisartan 40 mg is used to treat high blood pressure by blocking angiotensin II receptors, helping widen blood vessels and reduce overall cardiovascular strain.

4. What is telmisartan tablet used for besides blood pressure?
Beyond lowering blood pressure, Telmisartan is also used for cardiovascular risk reduction in certain high-risk patients and offers additional kidney-protective benefits, particularly in diabetic patients, though this should always be guided by a physician.

5. What are azelnidipine uses?
Azelnidipine is used as a calcium channel blocker to treat hypertension, working by relaxing blood vessel walls to reduce peripheral resistance and lower blood pressure smoothly over a sustained period.

6. Is AZELIKEM T 40 safe for daily long-term use?
When prescribed and monitored by a physician, AZELIKEM T 40 is generally considered safe for long-term daily use in managing chronic hypertension.

7. Can azelnidipine and telmisartan be taken together?
Yes, this fixed-dose combination is specifically formulated to be taken together, as the two components work through complementary mechanisms for more effective and stable blood pressure control.

8. What is the best time to take AZELIKEM T 40?
It is generally recommended to take this medication at the same time each day, with or without food, as advised by your physician, to maintain consistent drug levels.

9. Does azelnidipine cause less rapid heartbeat than other calcium channel blockers?
Yes, Azelnidipine's gradual onset of action is associated with a lower incidence of reflex tachycardia compared to some faster-acting dihydropyridine calcium channel blockers.

10. Can AZELIKEM T 40 be taken by diabetic patients?
Telmisartan is generally considered favorable for patients with diabetes due to its kidney-protective properties, but use in diabetic patients should always be individualized and supervised by a physician.

11. What should I do if I miss a dose of AZELIKEM T 40?
If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next scheduled dose — in that case, the missed dose should be skipped rather than doubling up. Consult your physician for specific guidance.

12. Is AZELIKEM T 40 safe during pregnancy?
No, medications containing Telmisartan are contraindicated during pregnancy, particularly in the second and third trimesters, due to the risk of fetal harm. Physicians typically switch patients to alternative antihypertensives if pregnancy is planned or confirmed.

13. What are the common side effects of azelnidipine and telmisartan tablets?
Common side effects include mild dizziness, headache, fatigue, flushing, mild ankle swelling, and occasional gastrointestinal discomfort, most of which improve as the body adjusts to treatment.

14. Can this medication cause low blood pressure?
Yes, particularly in patients who are dehydrated, elderly, or taking other blood pressure–lowering medications, so close monitoring is important, especially during the initial weeks of therapy.

15. How long does it take for AZELIKEM T 40 to control blood pressure?
Blood pressure reduction is typically noticeable within one to two weeks, though the full therapeutic effect may take several weeks of consistent daily use to stabilize.

16. Are there any food or drug interactions to be aware of with telmisartan tablet use?
Patients should avoid excessive potassium supplementation or potassium-sparing diuretics without medical guidance, and should inform their doctor about all medications, including NSAIDs and other antihypertensives, to avoid interaction risks.

17. Can AZELIKEM T 40 be stopped suddenly?
No, this medication should not be stopped abruptly, as doing so can lead to a rebound rise in blood pressure. Any discontinuation should be gradual and supervised by a physician.

Conclusion

AZELIKEM T 40 by Steris Healthcare brings together the complementary mechanisms of Azelnidipine 16 mg and Telmisartan 40 mg to offer effective, well-tolerated, once-daily hypertension management. By combining a smooth, long-acting calcium channel blocker with a kidney-protective angiotensin receptor blocker, this combination addresses blood pressure control through two distinct pathways, reducing common tolerability concerns like reflex tachycardia while supporting stable, sustained blood pressure reduction across the full 24-hour dosing interval. As with any antihypertensive therapy, treatment should be initiated and monitored under medical supervision, with regular blood pressure, kidney function, and electrolyte checks to ensure long-term safety and effectiveness.

For Further Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +91 8824175417, +91 9982524671

Buy Now